These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8732162)

  • 1. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration.
    Tuszynski MH; Roberts J; Senut MC; U HS; Gage FH
    Gene Ther; 1996 Apr; 3(4):305-14. PubMed ID: 8732162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted intraparenchymal delivery of human NGF by gene transfer to the primate basal forebrain for 3 months does not accelerate beta-amyloid plaque deposition.
    Tuszynski MH; Smith DE; Roberts J; McKay H; Mufson E
    Exp Neurol; 1998 Dec; 154(2):573-82. PubMed ID: 9878192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates.
    Koliatsos VE; Clatterbuck RE; Nauta HJ; Knüsel B; Burton LE; Hefti FF; Mobley WC; Price DL
    Ann Neurol; 1991 Dec; 30(6):831-40. PubMed ID: 1789695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons.
    Emerich DF; Winn SR; Harper J; Hammang JP; Baetge EE; Kordower JH
    J Comp Neurol; 1994 Nov; 349(1):148-64. PubMed ID: 7852623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.
    Strömberg I; Wetmore CJ; Ebendal T; Ernfors P; Persson H; Olson L
    J Neurosci Res; 1990 Mar; 25(3):405-11. PubMed ID: 2325166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo gene therapy for Alzheimer's disease and spinal cord injury.
    Blesch A; Tuszynski M
    Clin Neurosci; 1995-1996; 3(5):268-74. PubMed ID: 8914793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells.
    Grill RJ; Blesch A; Tuszynski MH
    Exp Neurol; 1997 Dec; 148(2):444-52. PubMed ID: 9417824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor and Alzheimer's disease.
    Hefti F; Weiner WJ
    Ann Neurol; 1986 Sep; 20(3):275-81. PubMed ID: 3532929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic gene transfer to the adult primate central nervous system: in vitro and in vivo characterization of cells genetically modified to secrete nerve growth factor.
    Tuszynski MH; Senut MC; Ray J; Roberts J
    Neurobiol Dis; 1994 Nov; 1(1-2):67-78. PubMed ID: 9216988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts.
    Tuszynski MH; Grill R; Jones LL; McKay HM; Blesch A
    J Comp Neurol; 2002 Jul; 449(1):88-101. PubMed ID: 12115695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration.
    Mandel RJ; Gage FH; Clevenger DG; Spratt SK; Snyder RO; Leff SE
    Exp Neurol; 1999 Jan; 155(1):59-64. PubMed ID: 9918705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons.
    Tuszynski MH
    Cell Transplant; 2000; 9(5):629-36. PubMed ID: 11144960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
    Hu L; Côté SL; Cuello AC
    Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor synthesis and its regulatory mechanisms: an approach to therapeutic induction of nerve growth factor synthesis.
    Furukawa S; Furukawa Y
    Cerebrovasc Brain Metab Rev; 1990; 2(4):328-44. PubMed ID: 1980419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
    Tuszynski MH; Thal L; Pay M; Salmon DP; U HS; Bakay R; Patel P; Blesch A; Vahlsing HL; Ho G; Tong G; Potkin SG; Fallon J; Hansen L; Mufson EJ; Kordower JH; Gall C; Conner J
    Nat Med; 2005 May; 11(5):551-5. PubMed ID: 15852017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct, complex effects of estrogens on basal forebrain cholinergic neurons.
    Bora SH; Liu Z; Kecojevic A; Merchenthaler I; Koliatsos VE
    Exp Neurol; 2005 Aug; 194(2):506-22. PubMed ID: 15893308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain.
    Tuszynski MH; Sang H; Yoshida K; Gage FH
    Ann Neurol; 1991 Nov; 30(5):625-36. PubMed ID: 1763889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nerve growth factor in the expression of trkA mRNA in cultured embryonic rat basal forebrain cholinergic neurons.
    Kojima M; Ikeuchi T; Hatanaka H
    J Neurosci Res; 1995 Dec; 42(6):775-83. PubMed ID: 8847739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRIB (NGF delivery) Cyto Therapeutics Inc.
    Cockett MI
    IDrugs; 1998 Jul; 1(3):362-7. PubMed ID: 18465562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.